Treatment with tandem [Y]DOTA-TATE and [Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy.

MLA

Seregni, E., et al. “Treatment with Tandem [Y]DOTA-TATE and [Lu]DOTA-TATE of Neuroendocrine Tumours Refractory to Conventional Therapy.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 41, no. 2, Feb. 2014, pp. 223–30. EBSCOhost, https://doi.org/10.1007/s00259-013-2578-5.

APA

Seregni, E., Maccauro, M., Chiesa, C., Mariani, L., Pascali, C., Mazzaferro, V., Braud, F., Buzzoni, R., Milione, M., Lorenzoni, A., Bogni, A., Coliva, A., Vullo, S., & Bombardieri, E. (2014). Treatment with tandem [Y]DOTA-TATE and [Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy. European Journal of Nuclear Medicine & Molecular Imaging, 41(2), 223–230. https://doi.org/10.1007/s00259-013-2578-5

Chicago

Seregni, E., M. Maccauro, C. Chiesa, L. Mariani, C. Pascali, V. Mazzaferro, F. Braud, et al. 2014. “Treatment with Tandem [Y]DOTA-TATE and [Lu]DOTA-TATE of Neuroendocrine Tumours Refractory to Conventional Therapy.” European Journal of Nuclear Medicine & Molecular Imaging 41 (2): 223–30. doi:10.1007/s00259-013-2578-5.